REQUEST A DEMO
Total
USD $0.00
Search more companies

Novella Pharma EOOD LTD (Новела Фарма ЕООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Novella Pharma EOOD LTD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Novella Pharma EOOD LTD (Новела Фарма ЕООД) is a company based in Bulgaria, with its head office in Varna. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on September 13, 2026. It currently has a total number of 10 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 109.41% in 2024. Over the same period, its total assets grew by 50.29%. The enterprise’s net profit margin increased by 3.07% in 2024.

Headquarters
Han Kubrat 34, Vh. A, Ap. 21
Varna; Varna; Postal Code: 9009

Contact Details: Purchase the Novella Pharma EOOD LTD (Новела Фарма ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Novella Pharma EOOD LTD (Новела Фарма ЕООД) report to view the information.
Registered Capital:
Purchase the Novella Pharma EOOD LTD (Новела Фарма ЕООД) report to view the information.
Financial Auditors:
Purchase the Novella Pharma EOOD LTD (Новела Фарма ЕООД) report to view the information.
Incorporation Date:
September 13, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novella Pharma EOOD LTD (Новела Фарма ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
109.41%
Total Operating Revenue
109.35%
Operating Profit
435.9%
EBITDA
430%
Net Profit/Loss for the Period
437.14%
Total Assets
50.29%
Total Equity
696.3%
Operating Profit Margin
3.41%
Net Profit Margin
3.07%
Return on Equity (ROE)
-42.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?